| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $2.78B | -7.2% |
| R&D Expense | $218.7M | -11.4% |
| SG&A Expense | $766.8M | +0.5% |
| Operating Income | -$1.96B | -1509.7% |
| Pre-tax Income | -$2.13B | -7224.7% |
| Income Tax | -$79.5M | -318.4% |
| Net Income | -$2.05B | — |
| EPS (Basic) | -$30.54 | — |
| EPS (Diluted) | -$30.54 |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.3M | -17.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $282.4M | -6.9% |
| Inventory | $533.7M | -7.6% |
| Current Assets | $1.22B | -7.0% |
| Total Assets | $6.42B | -25.0% |
| Current Liabilities | $998.8M | +19.8% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $83.0M | -70.4% |
| Capital Expenditures | $195.1M | -6.8% |
| Investing Cash Flow | -$149.9M | +20.1% |
| Financing Cash Flow | $48.8M | +118.4% |
| Free Cash Flow | -$112.1M | -258.1% |
| — |
| Long-term Debt |
| $2.49B |
| +2.7% |
| Total Liabilities | $3.44B | -3.3% |
| Stockholders' Equity | $2.98B | -40.4% |